Serum-Potassium and Serum-Calcium in Insulin Shock Therapy

Clegg, J. L.

doi:10.1016/s0140-6736(00)60523-8

Cited by 3 publications

(1 citation statement)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This possibility must remain a suggestion, however, until determinations of intracellular levels of potassium are made in man following insulin therapy and until the amount which may shift into the liver can be determined. In the normal individual, as well as the diabetic, insulin is known to decrease the serum potassium levels (4,29,30). The exact mechanism of this action of insulin on serum potassium is not known, but it has been suggested that it is correlated with shifts of glucose and phosphate into the cell, for formation of a potassium hexosephosphate (see Figure 2), or into the liver in glycogenesis (4,29,31,32).…”

Section: Discussionmentioning

confidence: 99%

Serum Potassium, Magnesium, and Calcium Levels in Diabetic Acidosis

Martin¹,

Wertman²

1947

J. Clin. Invest.

132

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Serum Potassium, Magnesium, and Calcium Levels in Diabetic Acidosis

Martin¹,

Wertman²

1947

J. Clin. Invest.

132

View full text Add to dashboard Cite

Use of Potassium in Protracted Insulin Coma

Stark¹

1949

Arch NeurPsych

View full text Add to dashboard Cite

THE PROBLEM of protracted coma is one which faces most institutions that undertake to treat psychotic patients with insulin. According to Lester,1 it occurs once in every 1,887 normal comas. Its seriousness appears fairly obvious when thorough studies and proper clinical evaluation of the patient are undertaken and the resultant mortality and complications reviewed. Therapy of protracted coma, however, has been indefinite and controversial. The approaches in handling the problem have been manifold. The purpose of this paper is to add further to the reported cases of protracted coma and to present a relatively new mode of therapy with a possible explanation for its use. It is our aim to present the course of 2 patients in protracted coma and to indicate fully our mode of therapy for each and then to present an outline of therapy for patients in such clinical states.The state of protracted coma occurring during insulin therapy is characterized by several dominant features, all of which vary from patient to patient : ( 1 ) a normal blood sugar level and/or hypoglycemia; (2) a state of dehydration and disturbed electrolyte balance;(3) a disturbance in the sympathetic and the parasympathetic function and balance; (4) a neurologic syndrome which varies in accordance with the different stages described by Himwich 2 during the course of hypoglycémie coma; (5) a failure to respond to the routine methods of therapy for hypoglycémie coma, and (6) a recovery phase charac¬ terized by the presence of an organic syndrome, a Korsakoff-like psy¬ chosis of varied duration.

show abstract

Action of hypoglycemia on coronary insufficiency and mechanism of ECG alterations

Egeli

Berkmen

1960

American Heart Journal

View full text Add to dashboard Cite

Serum-Potassium and Serum-Calcium in Insulin Shock Therapy

Cited by 3 publications

References 1 publication

Serum Potassium, Magnesium, and Calcium Levels in Diabetic Acidosis

Serum Potassium, Magnesium, and Calcium Levels in Diabetic Acidosis

Use of Potassium in Protracted Insulin Coma

Action of hypoglycemia on coronary insufficiency and mechanism of ECG alterations

Contact Info

Product

Resources

About